R1 RCM Inc. (NASDAQ:RCM) – Stock analysts at KeyCorp decreased their Q2 2021 earnings per share estimates for shares of R1 RCM in a research note issued on Tuesday, January 12th. KeyCorp analyst D. Hooker now forecasts that the healthcare provider will earn $0.06 per share for the quarter, down from their prior estimate of $0.07. KeyCorp has a “Overweight” rating and a $26.00 price target on the stock.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Tuesday, November 3rd. The healthcare provider reported $0.11 earnings per share (EPS) for the quarter. The business had revenue of $307.20 million during the quarter, compared to analyst estimates of $295.38 million. R1 RCM had a return on equity of 182.08% and a net margin of 4.02%. R1 RCM’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.01 earnings per share.

Several other research analysts also recently weighed in on the stock. ValuEngine downgraded shares of R1 RCM from a “buy” rating to a “hold” rating in a research report on Tuesday, December 1st. Royal Bank of Canada increased their price objective on shares of R1 RCM from $20.00 to $27.00 and gave the company an “outperform” rating in a research report on Wednesday, December 9th. Zacks Investment Research lowered shares of R1 RCM from a “hold” rating to a “strong sell” rating in a report on Friday, January 8th. BidaskClub lowered shares of R1 RCM from a “strong-buy” rating to a “buy” rating in a report on Wednesday, January 6th. Finally, Cantor Fitzgerald lifted their price objective on shares of R1 RCM from $18.00 to $22.00 and gave the company an “overweight” rating in a report on Wednesday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $22.40.

Shares of NASDAQ:RCM opened at $25.37 on Thursday. The company has a debt-to-equity ratio of 12.08, a current ratio of 1.27 and a quick ratio of 1.27. R1 RCM has a 1-year low of $7.12 and a 1-year high of $25.60. The company has a market capitalization of $2.96 billion, a PE ratio of 253.73, a PEG ratio of 20.19 and a beta of 0.57. The business has a fifty day moving average price of $22.61 and a 200-day moving average price of $17.55.

Institutional investors have recently modified their holdings of the business. BlackRock Inc. boosted its stake in shares of R1 RCM by 109.4% during the third quarter. BlackRock Inc. now owns 16,718,057 shares of the healthcare provider’s stock worth $286,714,000 after buying an additional 8,734,205 shares during the period. Snyder Capital Management L P acquired a new stake in R1 RCM in the 3rd quarter worth about $25,700,000. State Street Corp increased its holdings in R1 RCM by 45.2% in the 3rd quarter. State Street Corp now owns 3,333,700 shares of the healthcare provider’s stock valued at $57,173,000 after buying an additional 1,038,006 shares during the period. Principal Financial Group Inc. grew its position in R1 RCM by 1,975.5% in the third quarter. Principal Financial Group Inc. now owns 866,606 shares of the healthcare provider’s stock valued at $14,863,000 after acquiring an additional 824,852 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its position in R1 RCM by 66.7% during the 2nd quarter. Nuveen Asset Management LLC now owns 1,951,072 shares of the healthcare provider’s stock worth $21,754,000 after purchasing an additional 780,615 shares in the last quarter.

About R1 RCM

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Recommended Story: Why is the conference call important?

Earnings History and Estimates for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.